Has Annette Smick, MD received payments from drug or device companies?

Yes. Drug and device makers reported $56,003 in general payments to Annette Smick, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Annette Smick, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Annette Smick, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Annette Smick, MD

Child & Adolescent Psychiatry · Sioux Falls, SDNPI 1982654877

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $47,308 of the $56,003 with a category attached, or 84.5%. Sunovion Pharmaceuticals Inc. accounts for 79.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $27,035 and has fallen 83.4% since, to $4,500 in 2021.

$56,003in general payments, 2019–2025

Across 82 payments — averaging $682.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sunovion Pharmaceuticals Inc.$44K
AbbVie$9K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
Neurocrine Biosciences, Inc.$87

What the payments were for

Speaking & faculty fees$47,30884%
Travel & lodging$7,78214%
Food & beverage$9132%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	63	$44,257
AbbVie	14	$8,509
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$3,150
Neurocrine Biosciences, Inc.	2	$87

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LATUDA$43,510
VRAYLAR$8,439
CAPLYTA$3,150

How this compares

Too few child & adolescent psychiatry providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$11,975

Medicare patients

Services billed

215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AustedoDeutetrabenazine	13	$91,704
CaplytaLumateperone Tosylate	13	$21,027
Asenapine Maleate	14	$3,904
Ziprasidone Hcl	44	$3,018
Ramelteon	13	$2,596
Clozapine	14	$1,089
Duloxetine Hcl	77	$1,073
Lamotrigine	35	$1,019
Atropine Sulfate	17	$800
Aripiprazole	37	$641
Sertraline Hcl	29	$527
Mirtazapine	32	$491
Lurasidone Hcl	14	$472
Divalproex Sodium ErDivalproex Sodium	14	$431
Lithium Carbonate ErLithium Carbonate	22	$417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$3,150	$21,02713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few child & adolescent psychiatry providers in South Dakotaon file to place this against a meaningful peer group, so we don't.

Other child & adolescent psychiatry in Sioux Falls

Scott SchneiderSioux Falls$24K
Timothy SoundySioux Falls$2K
William GammeterSioux Falls$651
Nicole ChristensonSioux Falls$265
Adam PetersonSioux Falls$111
Peter WarholAberdeen$2K
Elizabeth Garcia JanisHill City$595
Ami GarriganHot Springs$283

See the full list for South Dakota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →